Form 4 for AVTR Avantor, Inc.
Accepted 2023-03-06 00:00:00 ET · period of report 2023-03-03 · accession 0001722482-23-000081 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-03 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,914 | 108.7K | -3% | -$97.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | S | D | 3,914 | $25.00 | 108,715 | D | — | — |